ライフサイエンスコーパス: aspiration pneumonia

1 epsis, pancreatitis), or direct lung injury (aspiration, pneumonia).

2 Secondary outcomes were splenic injury and aspiration pneumonia.

3 temic diseases including atherosclerosis and aspiration pneumonia.

4 mplementing strategies to reduce the rate of aspiration pneumonia.

5 utcome variable was a discharge diagnosis of aspiration pneumonia.

6 of bacterial cultures in cases of suspected aspiration pneumonia.

7 d as the predominant predisposing factor for aspiration pneumonia.

8 eria can be aspirated into the lung to cause aspiration pneumonia.

9 clinical problems: neurogenic dysphagia and aspiration pneumonia.

10 with microbiologically documented bacterial aspiration pneumonia.

11 In the treatment of aspiration pneumonia, 27.6% of physicians preferred path

12 ry to a cavitating pulmonary infection after aspiration pneumonia 6 weeks after resection.

13 ortion of patients with documented bacterial aspiration pneumonia among comatose ICU patients with sy

14 rdiopulmonary anomalies, cerebral palsy, and aspiration pneumonia and among patients with tracheoesop

15 CsA-MMF group died of nonimmunologic causes (aspiration pneumonia and arrhythmia) between 3 and 6 mon

16 The epidemiology of aspiration pneumonia and its impact on clinical and econ

17 iffer between the 43 patients with bacterial aspiration pneumonia and the 49 patients with non-bacter

18 at are associated with an increased risk for aspiration pneumonia and to determine the clinical and e

19 edures associated with an increased risk for aspiration pneumonia and to determine the impact on inte

20 operative pulmonary complications, including aspiration, pneumonia and hypoxia, impaired hypoxic vent

21 eosinophilic syndrome, parvovirus infection, aspiration pneumonia, and severe depression, respectivel

22 mplications, specifically bowel perforation, aspiration pneumonia, and splenic injury.

23 s of 95 institutionalized elders with severe aspiration pneumonia, and to investigate its relation to

24 The results show that at the site of aspiration pneumonia, anti-CD11b F(ab')2 did not inhibit

25 nella species were recovered from abscesses, aspiration pneumonias, burns, bites, and sinuses.

26 ciated with typical bacterial infections and aspiration pneumonia but not Legionella infection among

27 iated with a significantly increased risk of aspiration pneumonia, but not bowel perforation or splen

28 C-Ps also protected in a model of fatal aspiration pneumonia by heavily capsulated serotype 3.

29 aspiration pneumonia defined as pneumonia in patients wh

30 oratory, or radiologic evidence of bacterial aspiration pneumonia did not require antibiotics.

31 neumonia in patients with previous recurrent aspiration pneumonia episodes.

32 oor diagnostic value in separating bacterial aspiration pneumonia from aspiration pneumonitis based o

33 y half the patients with suspected bacterial aspiration pneumonia had this diagnosis confirmed by tel

34 theter in these 92 patients showed bacterial aspiration pneumonia in 43 patients (46.7%).

35 importance of adding anaerobic coverage for aspiration pneumonia in institutionalized elders needs t

36 iration (2 patients, with ensuing death from aspiration pneumonia in one patient).

37 ent significantly decreased the incidence of aspiration pneumonia in patients with previous recurrent

38 One patient developed aspiration pneumonia in the postoperative period.

39 Aspiration pneumonia increased in-hospital mortality (re

40 ssion, the few reported studies suggest that aspiration pneumonia is also associated with these poor

41 Aspiration pneumonia is common among frail elderly perso

42 Aspiration pneumonia is the leading cause of pneumonia i

43 Aspiration pneumonia is thought to be associated with a

44 wing problems (dysphagia); increased risk of aspiration pneumonia, malnutrition, and dehydration; and

45 ved survival in lethal bacteremic sepsis and aspiration pneumonia models of XDR A. baumannii infectio

46 ed: cellulitis (n = 1), esophagitis (n = 1), aspiration pneumonia (n = 1), and tube migration (n = 9)

47 Aspiration pneumonia occurs in approximately 1% of surgi

48 no systematic review regarding the impact of aspiration pneumonia on the outcomes in patients with CA

49 ts with symptoms suggesting either bacterial aspiration pneumonia or non-bacterial aspiration pneumon

50 AA was associated with an increased risk of aspiration pneumonia (OR, 1.63; 95% CI, 1.11-2.37).

51 three manifested other pathologic findings (aspiration, pneumonia, or thromboemboli).

52 patients with advanced dementia can prevent aspiration pneumonia, prolong survival, reduce the risk

53 Microbiological assessment of aspiration pneumonia revealed the absence of any predomi

54 In those with suspected bacterial aspiration pneumonia, stopping empirical antibiotic ther

55 Given that the rate of aspiration pneumonia varies among hospitals, we can impr

56 The overall prevalence of aspiration pneumonia was 0.8%.

57 In conclusion, aspiration pneumonia was associated with both higher in-

58 In contrast, aspiration pneumonia was associated with decreased ICU m

59 dergoing procedures other than tracheostomy, aspiration pneumonia was independently associated with a

60 plasms, fluid and electrolyte disorders, and aspiration pneumonia were the most common primary diagno